AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05331274 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise group
Description: 1 stage~* In a sitting position, pull the leg up and extend the knee forward~* Standing, bending forward and bending the knee~* Supine, tucked legs~* Maintaining spinal smoothness in crawling~* Prone heel pull to buttock~Stage 2~* Prone on forearms-hands~* Extending the supine hands to the knees~* Rounding and hollowing the waist in crawling~* Progressive sit-stand~* Standing up from sitting and putting on and taking off socks~* Reaching up while standing and maintaining the straightness of the spine~* Squatting~* Climbing and descending stairs~Stage 3~* Maintaining standing, arms forward~* Slipping hands on the bed while standing~* Initiating the standing throw and maintaining the position until the final interval~* Putting on and taking off socks while standing~* Taking weight towards the ground from a certain height~* Picking up different weights from the ground~* Push-pull items~* Crossing obstacles of certain height~* Walking a certain distance
Study NCT05331274 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pain training group
Description: The training provides participants with the opportunity to explain the central sensitization mechanism and also integrates the behavioral, psychological and environmental aspects that contribute to the persistence of pain. It is intended to teach that education reduces pain and improves endogenous pain inhibition, mental health, physical function, vitality and self-rated disability in patients with chronic pain, and reduces passive coping, kinesiophobia, and catastrophizing.~The same exercises will be applied as the exercise group.
Study NCT05894304 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Suspension system
Description: suspended from the handles of the straps by either their hands or feet while the non-suspended pair of extremities are in contact with the ground leading to muscle activation due to unstable base of support
Study NCT06575192 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ARTIA Reconstructive Tissue Matrix
Description: Surgical Implant
Study NCT05894304 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Scapular training exercises
Description: Scapular muscle strength by resistance
Study NCT05570110 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enoxolone
Description: one capsule of active or placebo in the evening
Study NCT05570110 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Enoxolone
Description: one capsule of active or placebo in the evening
Study NCT06507436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Herombopag tablets
Description: Herombopag tablets; dose 1 or dose 2, for 5 days
Study NCT05309200 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match OCE-205 is a sterile solution to be used for intravenous infusion.
Study NCT06507436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Herombopag placebo tablets
Description: Herombopag placebo tablets; dose 1 or dose 2, for 5 days
Study NCT05806541 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: laughter therapy
Description: Laughter therapy session will be applied online for 25-30 minutes once a week for 2 months by the researcher who has the Laughter therapy certificate to the application group. In the laughter therapy session, the practices of introducing the practitioner and introducing the therapy, breathing exercises for a healthy life, keeping the rhythm accompanied by music, turning the laughter that started as if it were childlike games into reality will be carried out.
Study NCT06553651 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryotechnology Necrosectomy Procedure
Description: Subjects undergo necrosectomy with 1.7 mm flexible cryoprobes, either concurrently with stent placement or post-placement, at the Investigator's discretion. The cryoprobe will freeze the necrotic tissue and extracted en-bloc. A maximum of 4 cryotechnology procedures will be performed, with each procedure aiming for significant debris removal and clinical improvement of walled-off pancreatic necrosis (WOPN) symptoms.
Study NCT06428058 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive sexual health curriculum
Description: This is a randomized, controlled, single blinded, trial, stratified by health profession, of the intervention versus waitlist control assessing the effects on sexual health knowledge, attitudes, and sexual history and counseling skills at medium (6-) and long-term (12 and 24 months) follow-up. At the end of the intervention as compared with waitlist controls.~The intervention was a 4-day, Afrocentric, comprehensive sexual health curriculum. Tanzanian faculty wrote the curriculum in English and Kiswahili to address the most common sexual health challenges clinicians experience in Tanzania. The 4-day curriculum covers sexual health across the lifespan, lesbian, gay, bisexual, and transgender (LGBT) and sexual violence, clinical skills training, ethics, and community resources and cultural considerations.
Study NCT06254586 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Aerobic exercises
Description: This group received a single session of low-intensity cycling for 20 minutes. A period of reperfusion (3 to 5 minutes) were provided in both groups after 10 minutes of exercise training by deflating the BFR cuffs. The cuffs were inflated after 5 minutes of reperfusion, and the exercises were completed in both groups.
Study NCT06329063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vasopressin
Description: Administration of vasopressin (20 IU) (oral spray)
Study NCT06254586 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resisted exercises
Description: This group received four sets of 15 repetitions of knee extension, hamstring curls, and standing calf raises (20-40% 1RM) with 30 sec to 1 minute rest period between sets. A period of reperfusion (3 to 5 minutes) were provided in both groups after 10 minutes of exercise training by deflating the BFR cuffs. The cuffs were inflated after 5 minutes of reperfusion, and the exercises were completed in both groups.
Study NCT06575192 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No Intervention
Description: No ADM
Study NCT06468228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lutikizumab
Description: Subcutaneous injection
Study NCT05095974 — intervention group
Intervention type: DEVICE
Intervention: ultrasonography
Description: Ultrasound assessment will performed with parturient in the supine position using Mindray device (DC-N6, with a phased array transducer, model P4-2, 3-6 MHz). A C60x 5-2 MHz convex transducer will used for lung ultrasound (Mindray device (DC-N6, with a phased array transducer, model P4-2, 3-6 MHz).The Echo Comet Score (ECS) will obtained by the 28-rib interspaces technique dividing the chest wall in 12 areas on the left side (from the second to the fourth intercostal space) and 16 (from the second to the fifth intercostal space) on the right anterior and lateral hemithorax.
Study NCT06468228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneous injection
Study NCT05426733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Odevixibat
Description: Odevixibat is a small molecule inhibitor of the ileal bile acid transporter (IBAT).
Study NCT06465316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood and urine sample collection
Study NCT06465316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration and biopsy
Study NCT06465316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow aspiration and biopsy
Study NCT06465316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT
Study NCT06465316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iberdomide
Description: Given PO
Study NCT06465316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06465316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT06465316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teclistamab
Description: Given SC
Study NCT05302908 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NuestraSaludSegura
Description: It blends peer navigation and mHealth
Study NCT06271291 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study NCT04994717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Description: Continuous intravenous (cIV) infusion
Study NCT04994717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low-intensity chemotherapy regimen
Description: Intravenous (IV), oral (PO), subcutaneous (SC), or intrathecal (IT) administration.
Study NCT04994717 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SOC chemotherapy regimen
Description: Intravenous (IV), oral (PO), subcutaneous (SC), or intrathecal (IT) administration.
Study NCT04809740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluate implementation of navigator-delivered Home ePRO for all cancer patients
Description: evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites; 2) examine the barriers, facilitators, and implementation strategies used in implementing navigator-delivered Home ePRO; and 3) assess the impact of Home ePRO on clinical and utilization outcomes
Study NCT06179511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD9829
Description: AZD9829 will be administered by IV infusion
Study NCT05065970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Felzartamab
Description: anti-CD38+ monoclonal antibody
Study NCT05065970 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo comparator
Study NCT04817735 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: TAVI
Description: TAVI sizing with dedicated algorithm
Study NCT04372914 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: BRB Lozenges
Description: Each lozenge is made from 1 gram of freeze-dried black raspberry powder (equivalent to \~5 black raspberries) in the form of a dissolvable slow-release lozenge.
Study NCT06329063 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of placebo (oral spray)
Study NCT04966481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Administered on an outpatient basis
Study NCT04966481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Given intravenously over approximately 60 minutes
Study NCT04966481 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Description: Given intravenously over approximately 60 minutes
Study NCT06798727 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SMUP-IA-01(low-dose)
Description: A single knee administration of SMUP-IA-01(low-dose, 4.0 x 10\^6 cells/2mL)
Study NCT06798727 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SMUP-IA-01(mid-dose)
Description: A single knee administration of SMUP-IA-01(mid-dose, 1.0 x 10\^7 cells/2mL)
Study NCT06798727 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: High Hyal Plus
Description: A single knee administration of Hyaluronic acid(1% Sodium Hyaluronate 20mg/2ml)
Study NCT06800573 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: including strengthening exercises for deep neck flexors, rhomboids, lower trapezius and serratus anterior, (2 sets of 10 repetitions per day) and stretching exercises for pectoralis muscles (20seconds hold, 5 repetition.
Study NCT06800573 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lying posture with progression
Description: Exercise 1, the lying posture with leg extension progression, was aimed to stretch the anterior muscle chain (diaphragm, pectoralis minor, scalene, sternocleidomastoid, intercostalis, iliopsoas, arm, forearm, and hand flexors)(Bonetti et al., 2010).~Exercise 2, the lying posture with flexion of the thighs, was intended to stretch the posterior chain (upper trapezius, levator scapulae, suboccipital, erector spinae, gluteus maximus, ischiotibial, triceps surae, and foot intrinsic muscles).
Study NCT06800573 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: smartphone app exercises
Description: about 50 min a day, 4 days a week for an 8-week period also, performed exercises which were reminded by a smartphone app at predetermined times.
Study NCT06212115 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: mNGS
Description: metagenomics next generation sequencing
Study NCT05153369 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Care
Description: Enhanced care aims to educate participants about bipolar disorder using a didactic approach, in addition to teaching and practicing DBT skills in an applied and relevant manner based on the participant's needs. Participants will receive a total of four sessions (approx. 60 minutes in duration), to occur once a month, at a minimum. The content will be split up into psychoeducation (2 sessions) and selected DBT skills (2 sessions). Psychoeducation will be specific to youth bipolar disorder, covering topics such as symptoms of depression and hypo/mania, medications used to treat bipolar disorder, the role of biology and the environment in emotions, and vulnerability and protective factors to emotion dysregulation and mood episodes. The content of skills sessions will be individualized and based on participant needs and goals (e.g., learning and applying skills to optimize their overall functioning, address problem behaviors and/or stressors, and/or maintain commitment to treatment).
Study NCT05153369 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DBT Skills Training
Description: In DBT Skills Training, participants will only receive skills training and can choose to do this individually and/or with their individual family unit by including their parent(s) and/or sibling(s). Participants will receive 20-25 sessions (approx. 60 minutes in duration), to occur at least biweekly. Skills training will include the five standard youth DBT modules: psychoeducation about DBT and bipolar disorder, mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness, and walking the middle path. The primary focus of the skills training is to impart knowledge and acquire and strengthen pragmatic skills to replace dysfunctional behaviors. If participants choose to include their family members, they will be encouraged to coach one another in effective use of skills.
Study NCT05153369 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy Full Intervention
Description: The DBT full intervention is based on Miller et al.'s DBT for suicidal youth, with modifications for youth with BD. DBT will be conducted over 1 year with approximately 40-50 sessions. Sessions will alternate between individual and skills training sessions. Family involvement in skills training will be strongly encouraged, however will be up to the participant to decide. Participants in Level 3 will complete diary cards tailored for this population, assessing daily mood, suicidality, sleep, and medication adherence. Participants will report use of specified DBT skills on the diary card, and individualized treatment goals will be incorporated into the diary card (e.g., alcohol use). In addition, Level 3 will include skills coaching by phone (via phone and/or text). These brief, structured calls and/or texts function to promote skills generalization by helping the participant and any participating family member(s) use skills to achieve goals and solve problems.
Study NCT05519449 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JANX007
Description: JANX007 is dosed via IV in a 21- or 28-day cycle.
Study NCT05105581 — intervention group
Intervention type: BEHAVIORAL
Intervention: Quality of life scale
Description: 1. To assess the quality of life of patient~2. To assess the degree of OCD
Study NCT05524623 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: percutaneous microelectrolysis in myofascial trigger points of the trapezius
Description: percutaneous microelectrolysis with or without current emission in the treatment of cervical pain in myofascial trigger points of the trapezius
Study NCT05524623 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: percutaneous microelectrolysis in myofascial trigger points of the trapezius
Description: percutaneous microelectrolysis with or without current emission in the treatment of cervical pain in myofascial trigger points of the trapezius
Study NCT05358522 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid Prescribing Report Cards
Description: Initial comparison: Clinicians will receive an initial peer comparison feedback report by email in which their post-operative opioid prescribing for patients undergoing their top 3 procedures is compared to the guideline recommended doses and the mean prescribing doses by other University of Pennsylvania Health System (UPHS) prescribers for each of those 3 procedures since the start of the baseline period.~Furthermore, in an attached report, for each of the 3 procedures, the mean patient reported ability to manage pain one week at home after the procedure will be displayed for those who received guideline compliant dosages of opioids relative to those who received higher than guideline recommended amounts.~Monthly comparison: On a monthly basis clinicians will get a report providing similar peer comparison feedback as above but with a monthly trend line of their performance since the start of the intervention.
Study NCT06800391 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Capecitabine 1250 mg/m2 /day - Cyclophosphamide 50Mg/day
Description: Capecitabine (1250 mg/m2 /day) and Cyclophosphamide (50 mg/day) continuous daily dosing. Cycles are to be repeated every 28 days for a total of 6 cycles.
Study NCT06801080 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HealthySteps (https://www.zerotothree.org/our-work/healthysteps/)
Description: Within the DoD, most elements of the civilian HS model copyrighted by ZeroToThree.org were implemented. However, there were some modifications to accommodate the unique environment of the military community. The pilot utilized the pre-existing Military Family Life Counseling Program (MFLC) staff to serve as HS Specialists at participating clinics. MFLCs were hired and trained in the HS model through the HS Institute provided by ZeroToThree.org. Although the DoD pilot offered all 3 tiers of targeted care standard for the HS model, note that the DoD pilot did not offer a 24-hour parent support line at tier 1. Also, the DoD pilot required participating pilot clinics to utilize a modified version of the Tufts Survey of Well-Being of Young Children (SWYC; https://www.tuftsmedicine.org/medical-professionals-trainees/academic-departments/department-pediatrics/survey-well-being-young-children) to provide augmented screenings for infants at all tiers of pilot service provision.
Study NCT06801080 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual (TAU)
Description: The comparison clinics included in this intervention were selected to represent pediatric care within military treatment facilities throughout the DHA medical system located at Army, Navy, Marine Corps, and Air Force facilities. There is variability in pediatric practice across military service branches. However, all clinics follow the American Academy of Pediatrics Bright Futures guidelines.
Study NCT06800729 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TIX100, an orally available inhibitor of thioredoxin-interacting protein
Description: TIX100, an orally available inhibitor of thioredoxin-interacting protein
Study NCT06800729 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT06800469 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Microbiota analysis
Description: Upon acquisition of informed consent, fecal, digiunal mucosa, biliary and pancreatic fluid samples will be collected for microbiota analysis
Study NCT06800482 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: online outpatient follow-up
Description: The investigators use Huayitong APP for the post-operating follow-up of participants with papillary thyroid cancer
Study NCT06801327 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Simeox
Description: The Investigators chose to evaluate this device for respiratory physiotherapy in our patients because it is the only one that offers innovative technology, as, unlike other commercially available devices, it does not require the patient to perform forced breathing. Instead, the patient can exhale calmly at tidal volume. This is expected to reduce the patient's effort and improve compliance with treatment. Furthermore, the vibratory signal with small, rapid, and sequential depressions within the airways could be more effective in mobilizing mucus from the airways, preventing collapse.
Study NCT06800560 — intervention group
Intervention type: OTHER
Intervention: MenoScale
Description: Menopause symptom questionnaire
Study NCT05095974 — intervention group
Intervention type: DEVICE
Intervention: echocardiography
Description: MHz cardiac transducer for echocardiography with two-dimensional, M-mode, color-flow, continuous, pulsed wave and tissue Doppler imaging.
Study NCT06800560 — intervention group
Intervention type: OTHER
Intervention: Greene Climacteric Scale
Description: Menopause symptom questionnaire
Study NCT06800560 — intervention group
Intervention type: OTHER
Intervention: RAND 36-Item Health Survey 1.0
Description: Quality of life questionnaire